Devises / MESO
MESO: Mesoblast Limited - American Depositary Shares
10.96
USD
0.23
(2.06%)
Le taux de change de MESO a changé de -2.06% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 10.96 et à un maximum de 11.22.
Suivez la dynamique Mesoblast Limited - American Depositary Shares. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MESO Nouvelles
- Seeking Alpha Mesoblast: A Cautionary Hold On Regenerative Medicine's Risky Edge (Upgrade)
- Benzinga Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - BrightView Hldgs (NYSE:BV), ArriVent BioPharma (NASDAQ:AVBP)
- Benzinga Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK)
- Benzinga Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday - Advance Auto Parts (NYSE:AAP), ATAI Life Sciences (NASDAQ:ATAI)
- Benzinga Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Mesoblast (NASDAQ:MESO)
- Benzinga Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aptevo Therapeutics (NASDAQ:APVO), AIRO Group Holdings (NASDAQ:AIRO)
- Benzinga Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Aptevo Therapeutics (NASDAQ:APVO), Arqit Quantum (NASDAQ:ARQQ)
- Investing Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor ® in Ischemic Heart Failure and Label Extension for Ryoncil ® in Adults With GvHD
- Investing FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil ®
- Benzinga Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Booz Allen Hamilton (NYSE:BAH), Betterware de Mexico SAPI (NYSE:BWMX)
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Seeking Alpha Mesoblast Limited 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:MESO)
- Seeking Alpha Mesoblast: Ryoncil Approval Overshadowed By Commercial Hurdles (NASDAQ:MESO)
Range quotidien
10.96
11.22
Range Annuel
5.78
22.00
- Clôture Précédente
- 11.17
- Ouverture
- 11.19
- Bid
- 10.96
- Ask
- 11.26
- Plus Bas
- 10.96
- Plus Haut
- 11.22
- Volume
- 180
- Changement quotidien
- -2.06%
- Changement Mensuel
- -8.67%
- Changement à 6 Mois
- -43.77%
- Changement Annuel
- 63.58%
16 juillet, mercredi
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 0.1%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.6%
12:30
USD
- Act
- Fcst
- 3.1%
- Prev
- 3.0%
13:15
USD
- Act
- Fcst
- 0.1%
- Prev
- -0.2%
13:15
USD
- Act
- Fcst
- 77.1%
- Prev
- 77.4%
13:15
USD
- Act
- Fcst
- -0.2%
- Prev
- 0.1%
13:15
USD
- Act
- Fcst
- 0.6%
- Prev
- 0.6%
14:00
USD
14:30
USD
- Act
- Fcst
- 0.681 M
- Prev
- 7.070 M
14:30
USD
- Act
- Fcst
- -0.032 M
- Prev
- 0.464 M
14:30
USD
- Act
- Fcst
- 0.093 M
- Prev
- -1.358 M
14:30
USD
- Act
- Fcst
- -0.023 M
- Prev
- 0.059 M
14:30
USD
- Act
- Fcst
- -0.801 M
- Prev
- -0.825 M
14:30
USD
- Act
- Fcst
- -0.640 M
- Prev
- 0.278 M
14:30
USD
- Act
- Fcst
- 0.169 M
- Prev
- 0.603 M
14:30
USD
- Act
- Fcst
- 1.803 M
- Prev
- -2.658 M
14:30
USD
- Act
- Fcst
- Prev
- -0.099 M
14:30
USD
- Act
- Fcst
- Prev
- -0.2%
18:00
USD
- Act
- Fcst
- Prev
22:30
USD
- Act
- Fcst
- Prev